1. Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias

   • Nawar Alhourani
   • Julian Wolfes
   • Lars Eckardt

   Review Open access 14 February 2024 Pages: 791 - 800

   

2. Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation

   • Lisa Voigtländer-Buschmann
   • Sarina Schäfer
   • Ulrich Schäfer

   Original Paper Open access 01 June 2023 Pages: 801 - 811

   

3. Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

   • Wolfgang Koenig
   • Elke S. Lorenz
   • Ioanna Gouni-Berthold

   Original Paper Open access 21 August 2023 Pages: 812 - 821

   

4. Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus

   • Hanna Fröhlich
   • Anna Bossmeyer
   • Tobias Täger

   Original Paper Open access 22 August 2023 Pages: 822 - 830

   

5. Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials

   • Madeleine Perrett
   • Nisha Gohil
   • Dipak Kotecha

   Original Paper Open access 01 September 2023 Pages: 831 - 841

   

6. β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction

   • Shungo Hikoso
   • Hirota Kida
   • the OCVC-Heart Failure investigators

   Original Paper 29 November 2023 Pages: 842 - 855

   

7. Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples

   • Erberto Carluccio
   • Frank L. Dini
   • on behalf of the Working Group on Heart Failure of the Italian Society of Cardiology

   Original Paper Open access 21 September 2023 Pages: 856 - 865

   

8. Adherence to drug therapy in patients with heart failure associated with reduced ejection fractions (HFrEF) during cardiac rehabilitation and after 3 and 6 months

   • Michal Oszczygiel
   • Heinz Völler
   • Axel Schlitt

   Original Paper 05 October 2023 Pages: 866 - 874

   

9. Sacubitril/valsartan and the risk of incident dementia in heart failure: a nationwide propensity-matched cohort study

   • Hyun-Jung Lee
   • Hyung-Kwan Kim
   • Yong-Jin Kim

   Original Paper 31 October 2023 Pages: 875 - 883

   

10. Incidence and progression of atrial fibrillation in patients with and without heart failure using mineralocorticoid receptor antagonists: a meta-analysis

    • Thalys Sampaio Rodrigues
    • Levindo Jose Garcia Quarto
    • Han S. Lim

    Original Paper 03 January 2024 Pages: 884 - 897

    

11. GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis

    • Alessandro Villaschi
    • Giuseppe Ferrante
    • Mauro Chiarito

    Original Paper 22 January 2024 Pages: 898 - 909

    

12. Sodium glucose cotransporter 2 inhibitors with cardiac arrhythmias in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized placebo-controlled trials

    • Bo Xu
    • Bo Kang
    • Jiecan Zhou

    Original Paper 14 February 2024 Pages: 910 - 923

    

13. Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study

    • Hyeong Jun Noh
    • Sung Joo Cha
    • Jin Kyung Hwang

    Original Paper 15 February 2024 Pages: 924 - 932

    

14. Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator

    • Maura M. Zylla
    • Julian Wolfes
    • Patrick Lugenbiel

    Original Paper Open access 19 February 2024 Pages: 933 - 941

    

15. Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset

    • Tommaso Bucci
    • Chiara Cardamone
    • Gregory Y. H. Lip

    Original Paper Open access 06 March 2024 Pages: 942 - 950

    

16. Beta blockers are associated with lower all-cause mortality among HFpEF patients

    • Joseph Ibrahim
    • Carly Fabrizio
    • Gavin W. Hickey

    Original Paper 02 May 2024 Pages: 951 - 958